GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) | 12/3/2025 4:20:12 PM | View | Proxy | SEC | Y 2024 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/4/2025 4:24:48 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $77,467,000 +54.9% | Assets $199,448,000 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/4/2025 4:11:32 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $77,467,000 +54.9% | Assets $199,448,000 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/7/2025 9:32:40 AM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $68,129,000 +64.2% | Assets $187,157,000 | EPS $0.10 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/7/2025 7:08:44 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $68,129,000 +64.2% | Assets $187,157,000 | EPS $0.10 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 6/18/2025 7:02:42 AM | View | Proxy | SEC | Y 2024 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/7/2025 9:34:28 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $52,511,000 +93.2% | Assets $167,949,000 | EPS -$0.05 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/7/2025 7:08:16 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $52,511,000 +93.2% | Assets $167,949,000 | EPS -$0.05 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/3/2025 9:26:25 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $169,117,000 +504.8% | Assets $164,236,000 | EPS -$0.51 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/3/2025 7:10:41 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $50,410,000 +159.1% | Assets $164,236,000 | EPS -$0.05 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 1/8/2025 4:21:17 PM | View | Financials | Earnings (Prelim) | SEC | Y 2024 | Export Earnings Model | ||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/12/2024 9:53:57 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $50,025,000 +613.2% | Assets $158,253,000 | EPS -$0.03 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/12/2024 9:31:51 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $50,025,000 +613.2% | Assets $158,253,000 | EPS -$0.03 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/8/2024 9:39:10 AM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $41,504,000 +2,674.3% | Assets $157,521,000 | EPS -$0.14 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/8/2024 7:13:11 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $41,504,000 +2,674.3% | Assets $157,521,000 | EPS -$0.14 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 6/18/2024 7:11:52 AM | View | Proxy | SEC | Y 2023 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/8/2024 9:29:01 AM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $27,178,000 | Assets $167,899,000 | EPS -$0.30 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/8/2024 7:10:03 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $27,178,000 | Assets $167,899,000 | EPS -$0.30 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 4/26/2024 4:30:30 PM | Small | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $27,963,000 | Assets $164,698,000 | EPS -$2.00 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/4/2024 6:35:48 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $19,453,000 | Assets $164,698,000 | EPS -$0.29 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 2/29/2024 4:57:20 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $27,963,000 | Assets $164,698,000 | EPS -$2.00 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 1/8/2024 7:21:54 AM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/8/2023 9:36:50 AM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $7,014,000 | Assets $203,100,000 | EPS -$0.41 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/8/2023 7:10:17 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $7,014,000 | Assets $203,100,000 | EPS -$0.41 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2023 9:36:52 AM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $1,496,000 | Assets $200,976,000 | EPS -$0.83 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2023 7:38:18 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $1,496,000 | Assets $200,976,000 | EPS -$0.83 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 6/5/2023 4:07:42 PM | View | Proxy | SEC | Y 2022 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/4/2023 4:32:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $140,739,000 | EPS -$0.48 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/4/2023 4:12:34 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $140,739,000 | EPS -$0.48 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 4/28/2023 4:13:55 PM | View | Proxy | SEC | Y 2022 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/30/2023 7:08:15 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $132,785,000 | EPS -$0.44 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/29/2023 4:19:50 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $132,785,000 | EPS -$2.29 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/9/2022 9:36:20 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $145,758,000 | EPS -$0.33 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/9/2022 7:37:07 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $145,758,000 | EPS -$0.33 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2022 9:17:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $157,938,000 | EPS -$1.07 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2022 7:16:31 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $157,938,000 | EPS -$1.07 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 6/15/2022 4:42:33 PM | View | Proxy | SEC | Y 2021 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/9/2022 9:36:37 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $221,127,000 | EPS -$0.45 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/9/2022 7:08:54 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $221,127,000 | EPS -$0.45 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/17/2022 7:41:28 AM | View | Financials | Earnings | SEC | Y 2021 | Assets $247,265,000 | EPS -$0.38 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/16/2022 4:11:08 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $247,265,000 | EPS -$1.32 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/8/2021 9:44:17 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $264,089,000 | EPS -$0.38 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/8/2021 8:11:00 AM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $264,089,000 | EPS -$0.38 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2021 9:30:54 AM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $282,591,000 | EPS -$0.33 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2021 8:08:43 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $282,591,000 | EPS -$0.33 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 6/4/2021 5:13:23 PM | View | Proxy | SEC | Y 2020 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/10/2021 9:41:24 AM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $292,941,000 | EPS -$0.23 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/10/2021 8:08:40 AM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $292,941,000 | EPS -$0.23 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 4/30/2021 4:15:21 PM | View | Proxy | SEC | Y 2020 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/9/2021 4:13:37 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $22,334,000 -62.3% | Assets $311,637,000 | EPS $0.13 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/9/2021 7:09:35 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $0 | Assets $311,637,000 | EPS -$0.22 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/9/2020 4:32:33 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $327,635,000 | EPS -$0.20 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/9/2020 7:20:42 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $0 | Assets $327,635,000 | EPS -$0.20 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/10/2020 5:07:22 PM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $10,091,000 -42.5% | Assets $341,401,000 | EPS $0.49 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/10/2020 8:15:10 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $10,091,000 -42.5% | Assets $341,401,000 | EPS $0.49 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 6/16/2020 6:04:04 AM | View | Proxy | SEC | Y 2019 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/11/2020 4:42:58 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $12,243,000 -25.5% | Assets $207,725,000 | EPS -$0.02 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/11/2020 7:13:58 AM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $12,243,000 -25.5% | Assets $207,725,000 | EPS -$0.02 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 4/27/2020 6:07:54 AM | View | Proxy | SEC | Y 2019 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/16/2020 5:03:47 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $59,215,000 -42.7% | Assets $151,436,000 | EPS -$0.89 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/12/2020 7:09:33 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $25,224,000 +20.6% | Assets $151,436,000 | EPS -$0.07 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/12/2019 4:24:08 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $155,888,000 | EPS -$0.24 | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/12/2019 8:02:20 AM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $155,888,000 | EPS -$0.24 | Export Earnings Model | ||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2019 1:15:16 PM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $17,554,000 -39.9% | Assets $165,709,000 | EPS -$0.23 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2019 8:02:06 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $17,554,000 -39.9% | Assets $165,709,000 | EPS -$0.23 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 6/3/2019 5:11:34 PM | View | Proxy | SEC | Y 2018 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/16/2019 5:03:08 PM | View | Proxy | SEC | Y 2018 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/8/2019 5:18:14 PM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $16,437,000 -50.6% | Assets $173,622,000 | EPS -$0.35 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/8/2019 4:14:02 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $16,437,000 -50.6% | Assets $173,622,000 | EPS -$0.35 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 4/30/2019 4:43:40 PM | View | Proxy | SEC | Y 2018 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/15/2019 2:21:07 PM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $103,269,000 -40.4% | Assets $190,300,000 | EPS -$2.55 | |
| Avadel Pharmaceuticals Plc (AVDL) | 3/15/2019 7:01:38 AM | View | Financials | Earnings | WIRE | Y 2018 | Rev $20,920,000 -39.8% | Assets $190,300,000 | EPS -$1.71 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/5/2018 5:19:07 PM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $19,826,000 -50.0% | Assets $269,006,000 | EPS -$0.43 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/5/2018 9:05:43 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $19,826,000 -50.0% | Assets $269,006,000 | EPS -$0.43 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/7/2018 5:26:43 PM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $29,230,000 -36.9% | Assets $295,236,000 | EPS -$0.09 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/7/2018 9:02:52 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $29,230,000 -36.9% | Assets $295,236,000 | EPS -$0.09 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/17/2018 4:02:46 PM | View | Proxy | SEC | Y 2017 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/4/2018 2:11:17 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $33,293,000 -36.6% | Assets $351,861,000 | EPS -$0.32 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/2/2018 9:04:25 AM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $33,293,000 -36.6% | Assets $351,861,000 | EPS -$0.32 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/19/2018 9:02:52 AM | View | Correction | SEC | Y 2018 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/16/2018 5:37:09 PM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $173,245,000 +15.3% | Assets $253,277,000 | EPS $1.63 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/16/2018 5:29:38 PM | View | Correction | SEC | Y 2018 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/8/2018 9:26:26 AM | View | Financials | Earnings | SEC | Y 2017 | Rev $34,752,000 -19.3% | Assets $253,277,000 | EPS -$0.18 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/9/2017 3:11:25 PM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $39,675,000 +23.6% | Assets $277,427,000 | EPS $0.52 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 11/8/2017 9:15:07 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $39,675,000 +23.6% | Assets $277,427,000 | EPS $0.52 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/9/2017 5:14:17 PM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $46,311,000 +19.2% | Assets $259,160,000 | EPS $0.68 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 8/8/2017 11:29:34 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $46,311,000 +19.2% | Assets $259,160,000 | EPS $0.68 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/10/2017 5:36:16 PM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $52,507,000 +45.0% | Assets $258,688,000 | EPS $0.61 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/9/2017 7:36:00 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $52,507,000 +45.0% | Assets $258,688,000 | EPS $0.61 | Export Earnings Model | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 5/1/2017 3:58:10 PM | View | Proxy | SEC | Y 2016 | ||||||
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/28/2017 5:21:24 PM | Small | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $150,246,000 -13.2% | Assets $245,482,000 | EPS -$1.00 | |
| AVADEL PHARMACEUTICALS PLC (AVDL) | 3/7/2017 7:08:07 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $43,085,000 -3.3% | Assets $245,482,000 | EPS $0.12 | Export Earnings Model | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 11/14/2016 4:44:47 PM | Small | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $32,087,000 -32.2% | Assets $247,985,000 | EPS -$0.48 | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 11/7/2016 4:35:46 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $32,087,000 -32.2% | Assets $247,985,000 | EPS -$0.48 | Export Earnings Model | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 11/7/2016 8:04:31 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $32,087,000 -32.2% | Assets $247,985,000 | EPS -$0.48 | Export Earnings Model | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 8/15/2016 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $38,858,000 -20.0% | Assets $249,706,000 | EPS -$0.48 | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 8/8/2016 6:01:23 AM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $38,858,000 -20.0% | Assets $249,706,000 | EPS -$0.48 | Export Earnings Model | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 7/1/2016 5:33:22 PM | View | Proxy | SEC | Y 2015 | ||||||
| FLAMEL TECHNOLOGIES SA (AVDL) | 5/10/2016 4:53:20 PM | Small | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $36,216,000 +10.7% | Assets $255,010,000 | EPS -$0.15 | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 5/9/2016 5:27:10 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $36,216,000 +10.7% | Assets $255,010,000 | EPS -$0.15 | Export Earnings Model | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 3/15/2016 3:09:29 PM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $173,009,000 +1,055.3% | Assets $215,081,000 | EPS $0.96 | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 3/10/2016 8:49:55 AM | View | Financials | Earnings | SEC | Y 2015 | Rev $44,568,000 | Assets $215,081,000 | EPS $1.75 | Export Earnings Model | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 10/1/2015 5:16:40 PM | Small | View | Financials | 20-F/A | SEC | Y 2014 ending: 12/31/2014 | Rev: $14,975,000 +258.3% | Assets $174,205,000 | EPS -$2.36 | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 4/30/2015 4:06:23 PM | Small | View | Financials | 20-F | SEC | Y 2014 ending: 12/31/2014 | Rev: $14,975,000 +258.3% | Assets $174,205,000 | EPS -$2.36 | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 4/30/2014 5:25:11 PM | Micro | View | Financials | 20-F/A | SEC | Y 2013 ending: 12/31/2013 | Rev: $4,179,000 -44.5% | Assets $116,252,000 | EPS -$1.69 | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 4/30/2013 4:02:16 PM | Micro | View | Financials | 20-F | SEC | Y 2012 ending: 12/31/2012 | Rev: $7,534,000 -76.9% | Assets $117,311,000 | EPS -$0.13 | |
| FLAMEL TECHNOLOGIES SA (AVDL) | 4/27/2012 4:12:56 PM | Micro | View | Financials | 20-F | SEC | Y 2011 ending: 12/31/2011 | Rev: $32,600,000 -12.1% | Assets $69,402,000 | EPS -$0.36 |